T0	Participants 67 94	advanced colorectal cancer;
T1	Participants 379 431	patients previously treated with a fluoropyrimidine.
T2	Participants 524 570	chemotherapy and irinotecan in these patients.
T3	Participants 620 660	patients with advanced colorectal cancer
T4	Participants 1275 1325	44 patients to combination and 45 to single agent.
T5	Participants 1326 1424	Eight patients in the irinotecan arm and 4 in the combination arm had grade 3/4 diarrhoea (P=0.24)